Suppr超能文献

β-内酰胺酶和青霉素结合蛋白氨基酸取代对β-内酰胺酶阳性、阿莫西林/克拉维酸耐药的流感嗜血杆菌中阿莫西林/克拉维酸耐药性的作用。

Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.

作者信息

Matic Vlatka, Bozdogan Bülent, Jacobs Michael R, Ubukata Kimiko, Appelbaum Peter C

机构信息

Department of Pathology, Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.

出版信息

J Antimicrob Chemother. 2003 Dec;52(6):1018-21. doi: 10.1093/jac/dkg474. Epub 2003 Oct 29.

Abstract

The roles of beta-lactamase and alterations in penicillin-binding protein in the development of amoxicillin and amoxicillin/clavulanate resistance in two beta-lactamase-positive, amoxicillin/clavulanate-resistant (BLPACR) strains of Haemophilus influenzae were investigated. Seven beta-lactamase-negative, ampicillin-resistant (BLNAR) strains were also studied for comparison of their resistance mechanisms. All strains had been recovered from patients in Japan. The TEM type beta-lactamase of the two BLPACR strains had 100% homology with the amino acid sequences of published TEM-1 beta-lactamase, showing that amoxicillin/clavulanate resistance was not associated with mutations in this beta-lactamase. However, these strains, as well as the seven BLNAR strains, had multiple mutations in ftsI, which encodes penicillin binding protein 3 (PBP3). The transformation of H. influenzae Rd strain with amplified ftsI genes from two BLPACR and two BLNAR strains enabled the selection of amoxicillin/clavulanate-resistant transformants with the same mutations as their parent strains. We concluded that amoxicillin/clavulanate resistance in the two BLPACR strains was due to changes in PBP3. The possibility of the presence of an extended spectrum beta-lactamase was excluded in the BLPACR strains studied.

摘要

研究了β-内酰胺酶以及青霉素结合蛋白的改变在两株β-内酰胺酶阳性、阿莫西林/克拉维酸耐药(BLPACR)流感嗜血杆菌菌株对阿莫西林及阿莫西林/克拉维酸耐药性形成中的作用。还研究了7株β-内酰胺酶阴性、氨苄西林耐药(BLNAR)菌株,以比较它们的耐药机制。所有菌株均从日本患者中分离得到。两株BLPACR菌株的TEM型β-内酰胺酶与已发表的TEM-1β-内酰胺酶氨基酸序列具有100%同源性,表明阿莫西林/克拉维酸耐药性与该β-内酰胺酶的突变无关。然而,这些菌株以及7株BLNAR菌株在编码青霉素结合蛋白3(PBP3)的ftsI基因中存在多个突变。用来自两株BLPACR菌株和两株BLNAR菌株的扩增ftsI基因转化流感嗜血杆菌Rd菌株,能够筛选出与亲本菌株具有相同突变的阿莫西林/克拉维酸耐药转化体。我们得出结论,两株BLPACR菌株对阿莫西林/克拉维酸的耐药性是由于PBP3的改变。在所研究的BLPACR菌株中排除了存在超广谱β-内酰胺酶的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验